Securities ▲▼ | Shares | Value ($K) | |||||
|---|---|---|---|---|---|---|---|
Q3 2024 ▲▼ | Q4 2024 ▲▼ | Change ▲▼ | Q3 2024 ▲▼ | Q4 2024 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Monte Rosa Therapeutics, Inc.(GLUE) | 0 | 5,652,922 | +5,652,922 | 0 | 39,231 | 45.22% | +39,231 |
| Tempest Therapeutics, Inc.(TPST) | 0 | 3,507,055 | +3,507,055 | 0 | 2,927 | 3.37% | +2,927 |
| Adverum Biotechnologies, Inc. | 506,821 | 506,821 | 0 | 3,558 | 2,367 | 2.73% | -1,191 |
| Gritstone Oncology, Inc. | 3,561,150 | 0 | -3,561,150 | 2,065 | 0 | — | -2,065 |
| Skye Bioscience, Inc.(SKYE) | 2,007,704 | 2,007,704 | 0 | 7,850 | 5,682 | 6.55% | -2,168 |
| CRISPR Therapeutics AG(CRSP) | 498,558 | 498,558 | 0 | 23,422 | 19,623 | 22.62% | -3,799 |
| Contineum Therapeutics, Inc.(CTNM) | 918,163 | 918,163 | 0 | 17,574 | 13,451 | 15.51% | -4,123 |
| Repare Therapeutics, Inc. | 2,646,657 | 2,646,657 | 0 | 9,105 | 3,467 | 4.00% | -5,637 |